Journal
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
Volume 7, Issue 2, Pages 72-86Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1756283X13508519
Keywords
Clostridium difficile infection; risk factors; management; recurrent infection; severe infection
Categories
Ask authors/readers for more resources
Clostridium difficile was first described as a cause of diarrhea in 1978 and in the last three decades has reached an epidemic state with increasing incidence and severity in both healthcare and community settings. There also has been a rise in severe outcomes from C. difficile infection (CDI). There have been tremendous advancements in the field of CDI with the identification of newer risk factors, recognition of CDI in populations previously thought not at risk and development of better diagnostic modalities. Several treatment options are available for CDI apart from metronidazole and vancomycin, and include new drugs such as fidaxomicin and other options such as fecal microbiota transplantation. This review discusses the epidemiology, risk factors and outcomes from CDI, and focuses primarily on existing and evolving treatment modalities.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available